Judge Allows Some Claims Vs Pfizer Over Celebrex Statements - CNNMoney.com (Bextra News)July 1st, 2008
Posted in Bextra | No Comments » Pfizer at Cowen and Company Health Care Conference - Final - Insurance News Net (Bextra News)July 1st, 2008UNIDENTIFIED SPEAKER: Well, good morning, and welcome to the Pfizer session this morning. We’re very pleased to have with us Dr. Joe Feczko, who is Senior Vice President and Chief Medical Officer of Pfizer. Pfizer has one of the broadest and deepest Read More The Montgomery law firm has filed 161 Bextra, Celebrex and Vioxx lawsuits to date. Montgomery, AL ( PRWEB ) April 15, 2005 — Law firm Beasley Allen, lead counsel for the first Vioxx lawsuit set for May, believes that Pfizer’s Bextra , a COX-2 Read More Posted in Bextra | No Comments » Pfizer at Cowen and Company Health Care Conference - Final - Insurance News Net (Bextra News)July 1st, 2008UNIDENTIFIED SPEAKER: Well, good morning, and welcome to the Pfizer session this morning. We’re very pleased to have with us Dr. Joe Feczko, who is Senior Vice President and Chief Medical Officer of Pfizer. Pfizer has one of the broadest and deepest Read More THURSDAY, Nov. 8 (HealthDay News) — Pulling the painkillers Vioxx and Bextra off the market to spare patients’ hearts may have ended up harming their stomachs, a new study suggests. Rates of gastrointestinal events serious enough to require Read More The Montgomery law firm has filed 161 Bextra, Celebrex and Vioxx lawsuits to date. Montgomery, AL ( PRWEB ) April 15, 2005 — Law firm Beasley Allen, lead counsel for the first Vioxx lawsuit set for May, believes that Pfizer’s Bextra , a COX-2 Read More The new rules would bar government advisers who receive money from a drug or device maker from voting on that company’s products. Expert advisers to the government who receive money from a drug or device maker would be barred for the first time Read More MONDAY, April 14 (HealthDay News) — Two widely used drugs — one lowers cholesterol and one is an anti-inflammatory — may be useful in controlling prostate cancer. New research being presented at the American Association for Cancer Research annual Read More Posted in Bextra | No Comments » F.D.A. Rule Limits Role of Advisers Tied to Industry - Der Spiegel (Bextra News)July 1st, 2008The new rules would bar government advisers who receive money from a drug or device maker from voting on that company’s products. Expert advisers to the government who receive money from a drug or device maker would be barred for the first time Read More THURSDAY, Nov. 8 (HealthDay News) — Pulling the painkillers Vioxx and Bextra off the market to spare patients’ hearts may have ended up harming their stomachs, a new study suggests. Rates of gastrointestinal events serious enough to require Read More Posted in Bextra | No Comments » Beasley Allen Believes Bextra Recall Was Long Overdue - PRWeb (Bextra News)July 1st, 2008The law firm is an outspoken leader in the call to remove Celebrex, Vioxx and other “Coxibs” from the market. It is terribly unfortunate that it has taken over 4 months for FDA and Pfizer to do the right thing and recall Bextra Montgomery, AL ( PRWEB Read More UNIDENTIFIED SPEAKER: Well, good morning, and welcome to the Pfizer session this morning. We’re very pleased to have with us Dr. Joe Feczko, who is Senior Vice President and Chief Medical Officer of Pfizer. Pfizer has one of the broadest and deepest Read More Posted in Bextra | No Comments » Celebrex Plus Lipitor Could Fight Prostate Cancer - Austin American-Statesman (Bextra News)June 30th, 2008MONDAY, April 14 (HealthDay News) — Two widely used drugs — one lowers cholesterol and one is an anti-inflammatory — may be useful in controlling prostate cancer. New research being presented at the American Association for Cancer Research annual Read More Vioxx was removed from the market in September 2004 after it was revealed that the drug increased the risk of heart attacks and strokes. Getty Images NPR.org , November 9, 2007 · Merck & Co. said Friday that it will pay nearly $5 billion to end tens Read More Copyright © 2007 ScoutNews, LLC. All rights reserved. FRIDAY, Feb. 9 (HealthDay News) — A new cox-2 painkiller called etoricoxib causes fewer upper gastrointestinal problems than the traditional pain medicine diclofenac, researchers report. “In the Read More UNIDENTIFIED SPEAKER: Well, good morning, and welcome to the Pfizer session this morning. We’re very pleased to have with us Dr. Joe Feczko, who is Senior Vice President and Chief Medical Officer of Pfizer. Pfizer has one of the broadest and deepest Read More THURSDAY, Nov. 8 (HealthDay News) — Pulling the painkillers Vioxx and Bextra off the market to spare patients’ hearts may have ended up harming their stomachs, a new study suggests. Rates of gastrointestinal events serious enough to require Read More Posted in Bextra | No Comments » F.D.A. Rule Limits Role of Advisers Tied to Industry - Der Spiegel (Bextra News)June 30th, 2008The new rules would bar government advisers who receive money from a drug or device maker from voting on that company’s products. Expert advisers to the government who receive money from a drug or device maker would be barred for the first time Read More Copyright © 2007 ScoutNews, LLC. All rights reserved. FRIDAY, Feb. 9 (HealthDay News) — A new cox-2 painkiller called etoricoxib causes fewer upper gastrointestinal problems than the traditional pain medicine diclofenac, researchers report. “In the Read More According to the Earth Policy Institute, China has overtaken the US as the world’s top consumer of four of the five basic food, energy and industrial commodities: grain, meat, coal and steel, lagging behind only in oil. This year’s national Read More FRIDAY, Nov. 9 (HealthDay News) — With Friday’s announcement of almost $5 billion to be paid out to those people claiming they were hurt by the now-withdrawn painkiller Vioxx, the drug’s maker, Merck & Co., may have hoped to end the glare of Read More UNIDENTIFIED SPEAKER: Well, good morning, and welcome to the Pfizer session this morning. We’re very pleased to have with us Dr. Joe Feczko, who is Senior Vice President and Chief Medical Officer of Pfizer. Pfizer has one of the broadest and deepest Read More Posted in Bextra | No Comments » Ketek, Avandia Among Drugs Doctors Won’t Take - Newsinferno.com (Bextra News)June 29th, 2008
Posted in Bextra | No Comments » 8 drugs doctors wouldn't take - MSNBC (Bextra News)June 28th, 2008
Posted in Bextra | No Comments » Beasley Allen Law Firm Leads National COX-2 Litigation - PRWeb (Bextra News)June 28th, 2008Beasley Allen is spearheading the review of over 31,000 claims against the manufacturers of Bextra, Celebrex, and Vioxx, having filed 161 cases to date. Montgomery, AL ( PRWEB ) April 14, 2005 — Beasley, Allen, Crow, Methvin, Portis & Miles, P.C Read More MONDAY, April 14 (HealthDay News) — Two widely used drugs — one lowers cholesterol and one is an anti-inflammatory — may be useful in controlling prostate cancer. New research being presented at the American Association for Cancer Research annual Read More The new rules would bar government advisers who receive money from a drug or device maker from voting on that company’s products. Expert advisers to the government who receive money from a drug or device maker would be barred for the first time Read More UNIDENTIFIED SPEAKER: Well, good morning, and welcome to the Pfizer session this morning. We’re very pleased to have with us Dr. Joe Feczko, who is Senior Vice President and Chief Medical Officer of Pfizer. Pfizer has one of the broadest and deepest Read More Posted in Bextra | No Comments » |
ArchivesCategories
MetaRecently Posted
| ||||||
